CHRISTOPHER PATUSKY - 17 Jul 2017 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
17 Jul 2017
Net transactions value
+$529
Form type
4
Filing time
03 May 2023, 16:30:46 UTC
Next filing
10 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Purchase $391 +3 +0.18% $130.24 1,683 17 Jul 2017 Direct
transaction UTHR Common Stock Purchase $385 +3 +0.18% $128.35 1,686 28 Jul 2017 Direct
transaction UTHR Common Stock Sale $726 -6 -0.36% $121.01 1,680 20 Oct 2017 Direct
transaction UTHR Common Stock Purchase $631 +5 +0.3% $126.20 1,685 20 Nov 2017 Direct
transaction UTHR Common Stock Sale $539 -5 -0.3% $107.71 1,680 20 Mar 2018 Direct
transaction UTHR Common Stock Purchase $684 +6 +0.36% $114.06 1,686 20 Apr 2018 Direct
transaction UTHR Common Stock Sale $208 -2 -0.12% $104.12 1,684 21 May 2018 Direct
transaction UTHR Common Stock Sale $420 -4 -0.24% $105.11 1,680 28 Dec 2018 Direct
transaction UTHR Common Stock Purchase $331 +4 +0.24% $82.83 1,684 10 Jun 2019 Direct F1
holding UTHR Common Stock 1,100 17 Jul 2017 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 reflects the reporting person's holdings as of May 3, 2023, the date of this Form 4.

Remarks:

The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy involving the securities of multiple issuers. The reporting person was unaware of the transactions at the time they occurred. Short swing profits resulting from these transactions have been returned to the Issuer.